In pancreatic cancer, excessive desmoplastic stroma severely
impedes
drug access to tumor cells. By reverting activated pancreatic stellate
cells (PSCs) to quiescence, all-trans retinoic acid (ATRA) can attenuate
their stromal synthesis and remodel the tumor-promoting microenvironment.
However, its modulatory effects have been greatly weakened due to
its limited delivery to PSCs. Therefore, we constructed a tripeptide
RFC-modified gelatin/oleic acid nanoparticle (RNP@ATRA), which delivered
ATRA in an enzyme-triggered popcorn-like manner and effectively resolved
the delivery challenges. Specifically, surface RFC was cleaved by
aminopeptidase N (APN) on the tumor endothelium to liberate l-arginine, generating nitric oxide (NO) for tumor-specific vasodilation.
Then, massive nanoparticles were pushed from the vessels into tumors,
showing 5.1- and 4.0-fold higher intratumoral accumulation than free
ATRA and APN-inert nanoparticles, respectively. Subsequently, in the
interstitium, matrix metalloproteinase-2-induced gelatin degradation
caused RNP@ATRA to rapidly release ATRA, promoting its interstitial
penetration and PSC delivery. Thus, activated PSCs were efficiently
reverted to quiescence, and stroma secretion and vascular compression
were reduced, thereby enhancing intratumoral delivery of small-molecule
or nanosized chemotherapeutics. Ultimately, RNP@ATRA combined with
chemotherapeutics markedly suppressed tumor growth and metastasis
without causing additional toxicities. Overall, this work provides
a potential nanoplatform for the efficient delivery of PSC-modifying
agents in pancreatic cancer and other stroma-rich tumors